Advertisement

AIDS and Behavior

, Volume 23, Issue 7, pp 1698–1707 | Cite as

Network Modeling of PrEP Uptake on Referral Networks and Health Venue Utilization Among Young Men Who Have Sex with Men

  • Kayo FujimotoEmail author
  • Peng Wang
  • Charlene A. Flash
  • Lisa M. Kuhns
  • Yucheng Zhao
  • Muhammad Amith
  • John A. Schneider
Original Paper

Abstract

The objective of this study is to identify individual-level factors and health venue utilization patterns associated with uptake of pre-exposure prophylaxis (PrEP) and to evaluate whether PrEP uptake behavior is further diffused among young men who have sex with men (YMSM) through health venue referral networks. A sample of 543 HIV-seronegative YMSM aged 16–29 were recruited in 2014–2016 in Chicago, IL, and Houston, TX. Stochastic social network models were estimated to model PrEP uptake. PrEP uptake was associated with more utilization of health venues in Houston and higher levels of sexual risk behavior in Chicago. In Houston, both Hispanic and Black YMSM compared to White YMSM were less likely to take PrEP. No evidence was found to support the spread of PrEP uptake via referral networks, which highlights the need for more effective PrEP referral network systems to scale up PrEP implementation among at-risk YMSM.

Keywords

Social network analysis PrEP Health care delivery system Young men who have sex with men Systems science methodology Exponential random graph models Auto-logistic actor attribute models 

Notes

Acknowledgements

This work was supported by the National Institutes of Health (1R01MH100021, 1R01DA039934, K23-MH109358-02), by Gilead Sciences, Inc. (IN-US-276-D120), and by UTHealth Innovation for Cancer Prevention Research Training Program (Cancer Prevention and Research Institute of Texas grant # RP160015). We acknowledge the contributions to this study of Angela Di Paola, Ju-Yeong Kim, and the YMAP staff in both Houston and Chicago.

Compliance with Ethical Standards

Conflicts of interest

K. Fujimoto, L. Kuhns, and J. Schneider have received research grants from Gilead Sciences, Inc. C. Flash serves on the scientific advisory board of Gilead Sciences, Inc.

Supplementary material

10461_2018_2327_MOESM1_ESM.docx (63 kb)
Supplementary material 1 (DOCX 63 kb)

References

  1. 1.
    Center for Disease Control and Prevention (CDC). HIV surveillance report: diagnosis of HIV infection in the United States and dependent areas, 2011. HIV/AIDS Statistics Overview; 2014.Google Scholar
  2. 2.
    Houston Health Department. HIV surveillance program. HIV infection in Houston: An epidemiologic profile 2010–2014. Houston, Texas; 2015.Google Scholar
  3. 3.
    Illinois Department of Public Health. Illinois HIV/AIDS/STD monthly surveillance update December 2014. Springfield, IL; 2015.Google Scholar
  4. 4.
    Chicago Department of Public Health. HIV/STI surveillance report, 2015. Chicago, IL: City of Chicago; December 2015.Google Scholar
  5. 5.
    Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefGoogle Scholar
  6. 6.
    McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefGoogle Scholar
  7. 7.
    Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefGoogle Scholar
  8. 8.
    Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med. 2016;176(1):75–84.CrossRefGoogle Scholar
  9. 9.
    Mera Giler R, Trevor H, Bush S, Rawlings K, McCallister S. Changes in truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: (2012–2016). In: 9th International AIDS society conference on HIV science 2017 July (pp. 23–26).Google Scholar
  10. 10.
    Smith DK, Van Handel M, Wolitski RJ, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.CrossRefGoogle Scholar
  11. 11.
    Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS. 2016;11(1):67–73.CrossRefGoogle Scholar
  12. 12.
    Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into practice: lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE. 2016;11(6):e0157324.CrossRefGoogle Scholar
  13. 13.
    Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.CrossRefGoogle Scholar
  14. 14.
    Robins G, Elliott P, Pattison P. Network models for social selection processes. Soc Netw. 2001;23(1):1–30.CrossRefGoogle Scholar
  15. 15.
    Wang P, Robins G, Pattison P, Lazega E. Social selection models for multilevel networks. Soc Netw. 2016;44:346–62.CrossRefGoogle Scholar
  16. 16.
    Schneider JA, Bouris A, Smith DK. Race and the public health impact potential of pre-exposure prophylaxis in the United States. J Acquir Immune Defic Syndr. 2015;70(1):e30–2.CrossRefGoogle Scholar
  17. 17.
    Khanna AS, Michaels S, Skaathun B, et al. Preexposure prophylaxis awareness and use in a population-based sample of young Black men who have sex with men. JAMA Intern Med. 2016;176(1):136–8.CrossRefGoogle Scholar
  18. 18.
    Levy ME, Wilton L, Phillips G II, et al. Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States. AIDS Behav. 2014;18(5):972–96.CrossRefGoogle Scholar
  19. 19.
    Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–54.CrossRefGoogle Scholar
  20. 20.
    Strauss BB, Greene GJ, Phillips G II, et al. Exploring patterns of awareness and use of HIV pre-exposure prophlaxis among young men who have sex with men. AIDS Behav. 2017;21(5):1288–98.CrossRefGoogle Scholar
  21. 21.
    Brooks RA, Landovitz RJ, Regan R, Lee SJ, Allen VC Jr. Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2015;26(14):1040–8.CrossRefGoogle Scholar
  22. 22.
    Kuhns LM, Hotton AL, Schneider J, Garofalo R, Fujimoto K. Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size. AIDS Behav. 2017;21(5):1376–82.CrossRefGoogle Scholar
  23. 23.
    Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res. 2013;11(7):520–7.CrossRefGoogle Scholar
  24. 24.
    Schneider JA, Walsh T, Cornwell B, Ostrow D, Michaels S, Laumann EO. HIV health center affiliation networks of black men who have sex with men: disentangling fragmented patterns of HIV prevention service utilization. Sex Transm Dis. 2012;39(8):598–604.CrossRefGoogle Scholar
  25. 25.
    Hyde JK, Shortell SM. The structure and organization of local and state public health agencies in the U.S.: a systematic review. Am J Prev Med. 2012;42(5 Suppl 1):S29–41.CrossRefGoogle Scholar
  26. 26.
    Blanchet K, James P. How to do (or not to do)… a social network analysis in health systems research. Health Policy Plan. 2012;27(5):438–46.CrossRefGoogle Scholar
  27. 27.
    Mays GP, Scutchfield FD. Improving public health system performance through multiorganizational partnerships. Prev Chronic Dis. 2010;7(6):A116.Google Scholar
  28. 28.
    Wholey DR, Gregg W, Moscovice I. Public health systems: a social networks perspective. Health Serv Res. 2009;44(5 Pt 2):1842–62.CrossRefGoogle Scholar
  29. 29.
    Varda D, Shoup JA, Miller S. A systematic review of collaboration and network research in the public affairs literature: implications for public health practice and research. Am J Public Health. 2012;102(3):564–71.CrossRefGoogle Scholar
  30. 30.
    Retrum JH, Chapman CL, Varda DM. Implications of network structure on public health collaboratives. Health Educ Behav. 2013;40(1 Suppl):13S–23S.CrossRefGoogle Scholar
  31. 31.
    Luke DA, Harris JK. Network analysis in public health: history, methods, and applications. Annu Rev Public Health. 2007;28:69–93.CrossRefGoogle Scholar
  32. 32.
    Mabry PL, Olster DH, Morgan GD, Abrams DB. Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med. 2008;35(2 Suppl):S211–24.CrossRefGoogle Scholar
  33. 33.
    Qualtrics. Qualtrics Software Version 2013 of the Qualtrics Research Suite. Provo, UT: Qualtrics; 2005.Google Scholar
  34. 34.
    Fujimoto K, Wang P, Kuhns LM, et al. Multiplex competition, collaboration, and funding networks among social and health organizations: towards organization-based HIV interventions for young men who have sex with men. Med Care. 2017;55(2):102–10.CrossRefGoogle Scholar
  35. 35.
    Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRefGoogle Scholar
  36. 36.
    Fujimoto K, Cao M, Kuhns LM, Li DH, Schneider JA. Statistical adjustment of network degree in respondent-driven sampling estimators: venue attendance as a proxy for network size among young men who have sex with men. Soc Netw. 2018;54:118–31.CrossRefGoogle Scholar
  37. 37.
    Fujimoto K, Flash CA, Kuhns LM, Kim J-Y, Schneider JA. Social networks as drivers of syphilis and HIV infection among young black men who have sex with men. Sex Transm Infect. 2018;94(5):365–71.CrossRefGoogle Scholar
  38. 38.
    Csardi G, Nepusz T. The igraph software package for complex network research. InterJ Complex Syst. 2006;1695:1–9.Google Scholar
  39. 39.
    Wang P, Robins G, Pattison P. PNet: a program for the simulation and estimation of exponential random graph models. Parkville: University of Melbourne; 2009.Google Scholar
  40. 40.
    Centers for Disease Control Prevention (CDC). Preexposure prophylaxis for the prevention of HIV infection in the United States—2014 clinical practice guideline; 2014.Google Scholar
  41. 41.
    Bush S, Magnuson D, Rawlings MK, Hawkins T, McCallister S, Mera Giler R. Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US. ASM Microbe Conference; 2016.Google Scholar
  42. 42.
    Hoots B, Finlayson T, Nerlander L, Paz-Bailey G. National HIV, Behavioral Surveillance Study Group. Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-20 US cities, 2014. Clin Infect Dis. 2016;63(5):672–7.CrossRefGoogle Scholar
  43. 43.
    Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–21.CrossRefGoogle Scholar
  44. 44.
    Flash CA, Landovitz R, Giler RM. Two years of Truvada for pre-exposure prophylaxis utilization in the US. J Int AIDS Soc. 2014;17(4Suppl 3):19730.CrossRefGoogle Scholar
  45. 45.
    Caceres CF, O’Reilly KR, Mayer KH, Baggaley R. PrEP implementation: moving from trials to policy and practice. PrEP implementation science: state-of-the-art and research agenda. 2015; 18(4S3).Google Scholar
  46. 46.
    Mayer KH, Chan PA, Patel RR, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–27.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Kayo Fujimoto
    • 1
    Email author
  • Peng Wang
    • 2
  • Charlene A. Flash
    • 3
  • Lisa M. Kuhns
    • 4
  • Yucheng Zhao
    • 5
  • Muhammad Amith
    • 6
  • John A. Schneider
    • 7
  1. 1.Department of Health Promotion and Behavioral Sciences, Center for Health Promotion and Prevention ResearchThe University of Texas Health Science Center at HoustonHoustonUSA
  2. 2.Faculty of Business and Law, Centre for Transformative InnovationSwinburne University of TechnologyHawthornAustralia
  3. 3.Division of Infectious Diseases, Department of MedicineBaylor College of MedicineHoustonUSA
  4. 4.Division of Adolescent Medicine, Department of Pediatrics, Feinberg School of MedicineAnn & Robert H. Lurie Children’s Hospital, and Northwestern UniversityChicagoUSA
  5. 5.Department of Biostatistics and Data Science, School of Public HealthThe University of Texas Health Science Center at HoustonHoustonUSA
  6. 6.School of Biomedical InformaticsThe University of Texas Health Science Center at HoustonHoustonUSA
  7. 7.Departments of Medicine and Public Health Sciences and the Chicago Center for HIV EliminationUniversity of ChicagoChicagoUSA

Personalised recommendations